Etentamig for Newly Diagnosed Patients
Phase 2/3, Multicenter, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Subjects With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Near Add Your Location
Sorting 15 by
Memorial Sloan Kettering Cancer Center
New York, NY
- Accepting patients
Blue Ridge Cancer Care (Roanoke)
Roanoke, VA
- Accepting patients
Colorado Blood Cancer Institute
Sarah Cannon at Presbyterian/St. Luke's Medical Center (HealthONE)
Denver, CO
- Accepting patients
- Accepting patients
- Accepting patients
Texas Oncology
Tyler, TX
- Accepting patients
- Accepting patients
Weill Cornell
New York, NY
- Accepting patients
Virginia Cancer Specialists
Fairfax, VA
- Accepting patients
Minnesota Oncology
Minneapolis, MN
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.